1.Selective addition of CXCR3+CCR4-CD4+ Th1 cells enhances generation of cytotoxic T cells by dendritic cells in vitro.
Sung Hee YOON ; Sun Ok YUN ; Jung Yong PARK ; Hee Yeun WON ; Eun Kyung KIM ; Hyun Jung SOHN ; Hyun Il CHO ; Tai Gyu KIM
Experimental & Molecular Medicine 2009;41(3):161-170
Increasing importance is being given to the stimulation of Th1 response in cancer immunotherapy because its presence can shift the direction of adaptive immune responses toward protective immunity. Based on chemokine receptor expression, CXCR3+CCR4-CD4+ T cells as Th1-type cells were investigated its capacity in monocyte-derived dendritic cell (DC) maturation and polarization, and induction of antigen specific cytotoxic T lymphocytes (CTL) in vitro. The levels of IL-4, IL-5 and IL-10 were decreased to the basal level compared with high production of IFN-gamma, TNF-alpha, and IL-2 in CXCR3+CCR4-CD4+ T cells stimulated with anti-CD3 and anti-CD28 antibodies. Co-incubation of activated CD4+ or CXCR3+CCR4-CD4+ T cells with DC (CD4+/DC or CXCR3+CD4+/DC, respectively) particularly up-regulated IL-12 and CD80 expression compared with DC matured with TNF-alpha and LPS (mDC). Although there was no significant difference between the effects of the CXCR3+CCR4-CD4+ and CD4+ T cells on DC phenotype expression, CXCR3+CD4+/DC in CTL culture were able to expand number of CD8+ T cells and increased frequencies of IFN-gamma secreting cells and overall cytolytic activity against tumor antigen WT-1. These results demonstrated that the selective addition of CXCR3+CCR4-CD4+ T cells to CTL cultures could enhance the induction of CTLs by DC in vitro, and implicated on a novel strategy for adoptive T cell therapy.
Antigens, CD4/*immunology
;
Cell Line
;
Cells, Cultured
;
Cytokines/immunology
;
Cytotoxicity, Immunologic
;
Dendritic Cells/cytology/*immunology
;
Humans
;
Interferon-gamma/biosynthesis
;
Receptors, CCR4/*immunology
;
Receptors, CXCR3/*immunology
;
T-Lymphocytes, Cytotoxic/*cytology/immunology
;
Th1 Cells/*immunology
2.New strategies in cancer immunotherapy.
Chinese Journal of Oncology 2011;33(12):943-946
3.Imbalance between Th1 and Th2 cells in cord blood is influenced by maternal allergic rhinitis and associated with atopic dermatitis during the first two years of life.
Hongfei LOU ; Yujing FU ; Chengshuo WANG ; Yang WANG ; Luo ZHANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2014;49(5):390-394
OBJECTIVETo investigate the influence of maternal atopy on cord blood effector T cells and to identify these biologic markers as predictors of atopic dermatitis (AD).
METHODSSeventy mother-infant pairs were recruited in this prospective birth cohort study. Suspected factors for allergy, including maternal allergic history, total serum IgE, and maternal age at birth, were collected. Mother peripheral blood samples and cord blood were obtained and assayed for the percentage of interferon-γ (IFN-γ) and interleukin 4 (IL-4) producing T cells(Th1 and Th2 respectively) using flow cytometry. Their offspring at the age of 2 years old were evaluated by their dermatologist whether they had AD. Statistical analysis was performed using multiple logistic regression models and receiver-operating characteristic curve was employed to predict atopic dermatitis.
RESULTSTwenty-one allergic and 49 nonallergic mothers were recruited in this study. During the first two years of life, 15.7% children (n = 11) developed a physician-diagnosed AD (all children were the only child in the family). In group with maternal allergic rhinitis, a significantly increased percentage of Th2 was observed in peripheral blood of mother (7.10[1.18;16.1]% vs. 0.37[0.25;0.72]%, U = 10.0, P < 0.05) and cord blood of newborns (1.02[0.57;1.34]% vs. 0.21[0.15;0.42]%, U = 127.5, P < 0.05), respectively. Maternal atopic history did not affect the percentage of Th1 cells in cord blood (0.69[0.40;1.12]% vs.0.50[0.31;0.66]%, U = 361.0, P > 0.05). Children with reduced Th1/Th2 ratio in cord blood had a higher risk to develop AD (OR = 1.72, P = 0.001) . The model including Th1/Th2, maternal allergy, maternal age at birth and maternal total IgE showed high ability to discriminate children with and without AD. AUC was 0.907 (95% CI: 0.804-1.011, P < 0.001).
CONCLUSIONSElevated IL-4⁺CD4⁺ T cells in cord blood were of relevance with maternal allergic history. Imbalance between Th1 cell and Th2 cell at birth are associated with maternal allergy and promoted subsequent AD development.
Adult ; Child, Preschool ; Dermatitis, Atopic ; immunology ; Female ; Fetal Blood ; cytology ; Flow Cytometry ; Humans ; Immunoglobulin E ; blood ; Infant ; Infant, Newborn ; Mothers ; Prospective Studies ; Rhinitis, Allergic ; blood ; immunology ; Th1 Cells ; cytology ; Th1-Th2 Balance ; Th2 Cells ; cytology
4.Correlation of Breg with CD4(+)T cells of peripheral blood in patients with CITP and its clinical significance.
Chang-Lin WU ; Qian WANG ; Lei ZHENG ; Da-Yong GU ; Jian-An HE ; Chao-Peng SHAO
Journal of Experimental Hematology 2013;21(6):1517-1521
This study was aimed to detect the level of the peripheral blood Breg and CD4(+) T cell subgroups in patients with chronic idiopathic thrombocytopenic purpura (CITP) before and after therapy, and to analyse the charge of related cytokines and their correlation, to explore their roles in the pathogenesis of CITP. A total of 35 CITP cases were taken as the research group and 35 healthy persons were served as the control group. The peripheral blood mononuclear cells (PBMNC) were separated, the percentages of Th1, Th17, Th22 and Breg cells were detected by flow cytometry before and after treatment of glucocorticoid, and the IFN-γ, IL-17, IL-22 and IL-10 levels from PBMNC culture supernatant also were determined by ELISA. The results showed that there was significant difference as compared with the healthy controls, the proportion of peripheral blood Th1, Th17, Th22 cell subgroups all increased in CITP patients before treatment with glucocorticoid, the regulatory B cells (Breg) ratio was reduced, the differences had statistical significance (P < 0.05), but the differences were no statistically significant after treatment with glucocorticoid (P > 0.05). The levels of IFN-γ, IL-17, IL-22 from culture supernatant all increased in CITP patients before treatment, the level of IL-10 was lower than that of the healthy control, the difference was statistically significant (P < 0.05), but the there were no statistically significant differences after treatment (P > 0.05). There were positive correlation between the Breg cells and IL-10 expression in CITP patients (P < 0.05), the Breg cells and Th1, Th17, Th22 cells showed a negative correlation, IL-10 and IFN-γ, IL-17, IL-22 levels also showed a negative correlation. It is concluded that the down-regulation of regulatory B cells proportion and the IL-10 level may participate in the mechanism of CD4(+) T cell immunity disorder in CITP, which can provide new targets and ideas for the clinical immune regulation therapy.
Adolescent
;
Adult
;
Aged
;
B-Lymphocytes, Regulatory
;
cytology
;
immunology
;
CD4-Positive T-Lymphocytes
;
cytology
;
immunology
;
Case-Control Studies
;
Cells, Cultured
;
Female
;
Humans
;
Interleukin-10
;
immunology
;
Male
;
Middle Aged
;
Purpura, Thrombocytopenic, Idiopathic
;
blood
;
immunology
;
Th1 Cells
;
Th17 Cells
;
Young Adult
5.Correlation between the expression of NF-kappaB and the T helper cell predominant differentiation in a rat model of otitis media with effusion.
Hua LIU ; Shou-qin ZHAO ; De-min HAN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2007;42(9):699-700
Animals
;
Male
;
NF-kappa B
;
metabolism
;
Otitis Media with Effusion
;
immunology
;
metabolism
;
physiopathology
;
Rats
;
Rats, Sprague-Dawley
;
Th1 Cells
;
cytology
;
Th2 Cells
;
cytology
6.Genetic controls of Th17 cell differentiation and plasticity.
Experimental & Molecular Medicine 2011;43(1):1-6
CD4+ T lymphocytes play a major role in regulation of adaptive immunity. Upon activation, naive T cells differentiate into different functional subsets. In addition to the classical Th1 and Th2 cells, several novel effector T cell subsets have been recently identified, including Th17 cells. There has been rapid progress in characterizing the development and function of Th17 cells. Here I summarize and discuss on the genetic controls of their differentiation and emerging evidence on their plasticity. This information may benefit understanding and treating immune diseases.
Animals
;
CD4-Positive T-Lymphocytes/cytology/*immunology
;
Cell Differentiation
;
Cell Lineage
;
Cytokines/*genetics
;
Epigenesis, Genetic
;
Gene Expression Regulation
;
Humans
;
Interleukin-17/immunology/metabolism
;
T-Lymphocytes, Regulatory
;
Th1 Cells/immunology
;
Th17 Cells/*immunology
;
Th2 Cells/immunology
;
Transcription Factors/*genetics
;
Transcription, Genetic
7.Expression of Th1 and Th2 type cytokines responding to HBsAg and HBxAg in chronic hepatitis B patients.
Millina LEE ; Myung Ae LEE ; Sung Ki LEE ; Minsik SON ; Sung Won CHO ; Sun PARK ; Hyung Il KIM
Journal of Korean Medical Science 1999;14(2):175-181
The cytokine pattern on viral antigen recognition is believed to exert a profound influence on the resolution of viral infections and viral clearance. This study was initiated to investigate whether a cytokine imbalance oriented toward Th2 type response plays a role in chronic hepatitis B. Cytokine profiles of peripheral blood mononuclear cells associated with chronic hepatitis B were analysed by RT-PCR. Upon HBsAg stimulation, expression of IFN-gamma, IL-2, IL-4, and IL-10 was detected in 41%, 8%, 41%, and 50% of the patients, respectively. Among these cytokines, the expression of IFN-gamma was associated with high levels of serum AST/ALT. However, we could not prove that Th2 type cytokines had a protective effect on hepatocytes. Upon HBxAg stimulation, there was no recognizable association of cytokine patterns with AST/ALT levels. In conclusion, production of a Th1 cytokine, IFN-gamma, by HBsAg-reactive cells was associated with hepatocyte damage in chronic hepatitis B, while no counteracting effect of Th2 cytokines produced by those cells was observed.
Cytokines/genetics
;
Cytokines/biosynthesis*
;
Hepatitis B Surface Antigens/pharmacology
;
Hepatitis B Surface Antigens/immunology*
;
Hepatitis B, Chronic/immunology*
;
Human
;
Interferon Type II/genetics
;
Interferon Type II/biosynthesis
;
Leukocytes, Mononuclear/immunology
;
Liver/cytology
;
Recombinant Fusion Proteins/pharmacology
;
Recombinant Fusion Proteins/immunology
;
Th1 Cells/immunology*
;
Th1 Cells/drug effects
;
Th2 Cells/immunology*
;
Th2 Cells/drug effects
;
Trans-Activators/pharmacology
;
Trans-Activators/immunology*
8.Differences in Circulating Dendritic Cell Subtypes in Pregnant Women, Cord Blood and Healthy Adult Women.
Sue SHIN ; Jee Young JANG ; Eun Youn ROH ; Jong Hyun YOON ; Jong Seung KIM ; Kyou Sup HAN ; Serim KIM ; Yeomin YUN ; Young Sook CHOI ; Ji Da CHOI ; Soo Hyun KIM ; Sun Jong KIM ; Eun Young SONG
Journal of Korean Medical Science 2009;24(5):853-859
Different subtypes of dendritic cells (DC) influence the differentiation of naive T lymphocytes into T helper type 1 (Th1) and Th2 effector cells. We evaluated the percentages of DC subtypes in peripheral blood from pregnant women (maternal blood) and their cord blood compared to the peripheral blood of healthy non pregnant women (control). Circulating DC were identified by flow cytometry as lineage (CD3, CD14, CD16, CD19, CD20, and CD56)-negative and HLA-DR-positive cells. Subtypes of DC were further characterized as myeloid DC (CD11c+/CD123+/-), lymphoid DC (CD11c-/CD123+++) and less differentiated DC (CD11c-/CD123+/-). The frequency of DC out of all nucleated cells was significantly lower in maternal blood than in control (P<0.001). The ratio of myeloid DC/lymphoid DC was significantly higher in maternal blood than in control (P<0.01). HLA-DR expressions of myeloid DC as mean fluorescence intensity (MFI) were significantly less in maternal blood and in cord blood than in control (P<0.001, respectively). The DC differentiation factors, TNF-alpha and GM-CSF, released from mononuclear cells after lipopolysaccharide stimulation were significantly lower in maternal blood than in control (P<0.01). The distribution of DC subtypes was different in maternal and cord blood from those of non-pregnant women. Their role during pregnancy remains to be determined.
Adult
;
Cell Differentiation
;
Dendritic Cells/*classification/cytology/immunology
;
Female
;
Fetal Blood/cytology/*immunology
;
Flow Cytometry
;
Granulocyte-Macrophage Colony-Stimulating Factor/metabolism
;
HLA-DR Antigens/metabolism
;
Humans
;
Lipopolysaccharides/pharmacology
;
Lymphocyte Activation
;
Pregnancy
;
T-Lymphocytes/cytology/immunology
;
Th1 Cells/cytology/immunology
;
Th2 Cells/cytology/immunology
;
Tumor Necrosis Factor-alpha/metabolism
9.T(H1) and T(H2) cells in children with mycoplasma pneumonia.
An-cun HOU ; Yan LU ; Li SHA ; Li-ge LIU ; Jing SHEN ; Yong XU
Chinese Journal of Pediatrics 2003;41(9):652-656
OBJECTIVETo Study T lymphocyte subsets, including T(H1) and T(H2) cells in peripheral blood mononuclear cells (PBMC) of children with mycoplasma pneumonia, understand immunopathogenesis and explore the possibility of immunotherapy of patients with mycoplasma pneumonia.
METHODSFresh peripheral blood samples of patients from two groups, group 1, mycoplasma pneumonia (MP) group (35 cases, 15 males and 20 females, age range 3 - 13 years, mean 9 years), and control group consisted of 28 healthy children (14 males and 14 females, age range 3 - 12 years, mean 7 years) were treated and run through the flow cytometry. The data were obtained by using Simultest IMK-Lymphocyte software and the percentage of CD(3)(+), CD(3)(+)CD(4)(+), CD(3)(+)CD(8)(+), CD(3)(-)CD(19)(+) and CD(3)(-)CD(16 + 56)(+) cells were counted. The percentage of T(H1) and T(H2) cells were gained through determination of intracellular cytokines IFN-gamma or IL-4 in CD(4)(+) cells by flow cytometry. The 35 patients with MP were hospitalized at our hospital. In addition to fever and cough, all the patents had abnormal X-ray findings and/or moist rale on auscultation of the lungs. The IgM antibody to Mycoplasma pneumoniae was positive in each patient. Immunoglobulins were measured, and PPD skin tests were performed in 30 out of the 35 patients with MP. T test and rank sum test by SPSS FOR WINDOWS 10.0 was used for statistical analysis.
RESULTSThe percentage of CD(3)(+) and CD(4)(+) T lymphocyte was 68.00 +/- 6.66 and 37.86 +/- 5.84, respectively, in MP group, and 63.71 +/- 7.92 and 34.54 +/- 6.23 in control group (P < 0.05). The percentage of T(H1) cells was 14.13 +/- 8.46 in patients and 20.77 +/- 6.89 in normal control group (P = 0.001). The percentage of NK cells was 15.57 +/- 12.16 and 20.39 +/- 9.64 in MP and control group (P < 0.01). The ratio of T(H1)/T(H2) in MP group was lower than that in control group (P < 0.05). However the percentage of CD(8), T(H2), B cells and CD(4)/CD(8) had no difference between the MP and control groups. The levels of IgG, IgA, and IgM in serum were normal in most of patients except for a few patients who had elevated IgA and IgM levels. The PPD skin tests were negative in 30 out of 35 patients.
CONCLUSIONIn this study a higher percentage of CD(3)(+), CD(4)(+) T lymphocyte and lower percentage of T(H1), NK cells in PBMC of patients with mycoplasma pneumonia were found. The ratio of T(H1) and T(H2) cells in patients was also lower. None of thirty patients had positive PPD skin tests. Unbalanced cell-mediated immunity with a tendency toward T(H2) existed in patients with MP. Therefore, immunomodulators may be useful in treatment of mycoplasma pneumonia.
Adolescent ; CD3 Complex ; blood ; CD4 Antigens ; blood ; CD8 Antigens ; blood ; Child ; Child, Preschool ; Female ; Flow Cytometry ; Humans ; Immunoglobulins ; blood ; Male ; Pneumonia, Mycoplasma ; blood ; immunology ; T-Lymphocyte Subsets ; cytology ; immunology ; Th1 Cells ; immunology ; Th2 Cells ; immunology
10.Induction of Th1 immune response against tumor by genetically engineered fusion of tumor cells and dendritic cells.
Weidong ZHANG ; Hong YANG ; Hongtao ZENG ; Zhuang CHEN
Chinese Journal of Hematology 2002;23(2):61-64
OBJECTIVETo study the antitumor activity of engineered fusion of tumor cell and dendritic cells (DC).
METHODSJ558 tumor cells were transfected with mouse IL-12 (mIL-12) gene and then fused with DCs to develop a hybrid-engineered tumor vaccine. BALB/c mice were challenged with wild-type J558 tumor cells 14 days after vaccinated with hybrid-engineered J558.
RESULTSmIL-12 was detected at (870 +/- 60) pg.(10(5) cells)(-1).ml(-1) in the culture supernatants and the cell-fusion rate was about 30% by co-focal microscopy. In addition, the lymphocytes from popliteal nodes and groin nodes of these mice vaccinated with hybrid-engineered J558 secreted higher levels of IFN-gamma than that of other control mice, and vaccination of mice with the fusion vaccine induced more efficient tumor-specific CTL cytotoxicity against wild-type tumor cells in vitro and with efficient antitumor immunity in vivo.
CONCLUSIONIt suggested that vaccination of mice with the fusion vaccine induced stronger Th1-dominant responses and this approach could perhaps be applied to clinical settings of DCs-based cancer vaccines.
Animals ; Cell Fusion ; Dendritic Cells ; cytology ; immunology ; Female ; Hybrid Cells ; cytology ; immunology ; Interferon-gamma ; metabolism ; Interleukin-12 ; genetics ; Mice ; Mice, Inbred BALB C ; Microscopy, Confocal ; Neoplasm Transplantation ; Neoplasms, Experimental ; immunology ; metabolism ; mortality ; Survival Rate ; T-Lymphocytes, Cytotoxic ; immunology ; Th1 Cells ; immunology ; Transfection ; Tumor Cells, Cultured ; cytology ; immunology